Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,439 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Obesity and psoriasis: from the Medical Board of the National Psoriasis Foundation.
Bremmer S, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl MG, Young M, Bebo BF Jr, Blauvelt A; National Psoriasis Foundation. Bremmer S, et al. Among authors: young m. J Am Acad Dermatol. 2010 Dec;63(6):1058-69. doi: 10.1016/j.jaad.2009.09.053. Epub 2010 Aug 7. J Am Acad Dermatol. 2010. PMID: 20692722 Review.
National Psoriasis Foundation clinical consensus on disease severity.
Pariser DM, Bagel J, Gelfand JM, Korman NJ, Ritchlin CT, Strober BE, Van Voorhees AS, Young M, Rittenberg S, Lebwohl MG, Horn EJ; National Psoriasis Foundation. Pariser DM, et al. Among authors: young m. Arch Dermatol. 2007 Feb;143(2):239-42. doi: 10.1001/archderm.143.2.239. Arch Dermatol. 2007. PMID: 17310004
OBJECTIVES: A task force of the National Psoriasis Foundation Medical Board was convened to evaluate the current severity criteria of mild, moderate, and severe psoriasis and to make recommendations concerning a 2-tiered categorization of severity based on current clinical practi …
OBJECTIVES: A task force of the National Psoriasis Foundation Medical Board was convened to evaluate the current severity criteria of mild, …
From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis.
Lebwohl M, Bagel J, Gelfand JM, Gladman D, Gordon KB, Hsu S, Kalb RE, Kimball AB, Korman NJ, Krueger GG, Mease P, Morison WL, Paller A, Pariser DM, Ritchlin C, Strober B, Van Voorhees A, Weinstein GD, Young M, Horn L. Lebwohl M, et al. Among authors: young m. J Am Acad Dermatol. 2008 Jan;58(1):94-105. doi: 10.1016/j.jaad.2007.08.030. Epub 2007 Nov 5. J Am Acad Dermatol. 2008. PMID: 17980456
A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1.
Strober BE, Clay Cather J, Cohen D, Crowley JJ, Gordon KB, Gottlieb AB, Kavanaugh AF, Korman NJ, Krueger GG, Leonardi CL, Schwartzman S, Sobell JM, Solomon GE, Young M. Strober BE, et al. Among authors: young m. Dermatol Ther (Heidelb). 2012 Dec;2(1):1. doi: 10.1007/s13555-012-0001-y. Epub 2012 Mar 17. Dermatol Ther (Heidelb). 2012. PMID: 23205324 Free PMC article.
A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 2.
Strober BE, Clay Cather J, Cohen D, Crowley JJ, Gordon KB, Gottlieb AB, Kavanaugh AF, Korman NJ, Krueger GG, Leonardi CL, Schwartzman S, Sobell JM, Solomon GE, Young M. Strober BE, et al. Among authors: young m. Dermatol Ther (Heidelb). 2012 Dec;2(1):2. doi: 10.1007/s13555-012-0002-x. Epub 2012 Mar 30. Dermatol Ther (Heidelb). 2012. PMID: 23205325 Free PMC article.
A series of critically challenging case scenarios in moderate to severe psoriasis: a Delphi consensus approach.
Strober B, Berger E, Cather J, Cohen D, Crowley JJ, Gordon KB, Gottlieb A, Horn EJ, Kavanaugh AF, Korman NJ, Krueger GG, Leonardi CL, Menter A, Schwartzman S, Sobell JM, Young M. Strober B, et al. Among authors: young m. J Am Acad Dermatol. 2009 Jul;61(1 Suppl 1):S1-S46. doi: 10.1016/j.jaad.2009.03.017. J Am Acad Dermatol. 2009. PMID: 19527820
6,439 results